Achieve Life Sciences Stock Today
| ACHV Stock | USD 3.27 0.03 0.93% |
Performance0 of 100
| Odds Of DistressOver 81
|
Achieve Life is selling for under 3.27 as of the 1st of February 2025; that is 0.93 percent increase since the beginning of the trading day. The stock's lowest day price was 3.17. Achieve Life has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 2nd of January 2025 and ending today, the 1st of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 13th of October 1995 | Category Healthcare | Classification Health Care |
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. The company has 34.39 M outstanding shares of which 3.85 M shares are presently shorted by private and institutional investors with about 14.59 trading days to cover. More on Achieve Life Sciences
Moving together with Achieve Stock
Moving against Achieve Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Achieve Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman of the Board, CEO | Richard Stewart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAchieve Life can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Achieve Life's financial leverage. It provides some insight into what part of Achieve Life's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Achieve Life Sciences (ACHV) is traded on NASDAQ Exchange in USA. It is located in 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1 and employs 22 people. Achieve Life is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 111.42 M. Achieve Life Sciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 34.39 M outstanding shares of which 3.85 M shares are presently shorted by private and institutional investors with about 14.59 trading days to cover.
Achieve Life Sciences currently holds about 29.38 M in cash with (24.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03.
Check Achieve Life Probability Of Bankruptcy
Ownership AllocationAchieve Life holds a total of 34.39 Million outstanding shares. Over half of Achieve Life's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Achieve Ownership Details
Achieve Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Long Focus Capital Management, Llc | 2024-09-30 | 248.1 K | |
| Goldman Sachs Group Inc | 2024-09-30 | 234.9 K | |
| Simplify Asset Management Inc. | 2024-09-30 | 217.8 K | |
| Lpl Financial Corp | 2024-09-30 | 191.3 K | |
| Raymond James & Associates | 2024-09-30 | 143.3 K | |
| Morgan Stanley - Brokerage Accounts | 2024-09-30 | 90.7 K | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 89.6 K | |
| Bank Of New York Mellon Corp | 2024-09-30 | 77.2 K | |
| Cvi Holdings Llc | 2024-06-30 | 71.7 K | |
| Franklin Resources Inc | 2024-09-30 | 3.9 M | |
| Propel Bio Management Llc | 2024-09-30 | 2.5 M |
Achieve Life Historical Income Statement
Achieve Stock Against Markets
Achieve Life Corporate Management
| Jaime Xinos | Executive Commercial | Profile | |
| Mark CPA | Chief Officer | Profile | |
| Jerry Wan | Principal Officer | Profile | |
| John MBA | CEO Director | Profile |
Already Invested in Achieve Life Sciences?
The danger of trading Achieve Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Achieve Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Achieve Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Achieve Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.